Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1993-02-10
1995-11-07
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
A61K 31165
Patent
active
054648700
ABSTRACT:
This invention relates to methods of inhibiting development of leukoplakia or malignant lesions in a patient comprising the step of administering an effective leukoplakia or malignant lesion inhibiting amount of fenretinide to a patient wherein the administration of the fenretinide incurs less significant undesirable side effects than administration of other vitamin A retinoid derivatives.
REFERENCES:
Chemical Abstracts 115: 41529r (1991).
Chiesa Fausto
Costa Alberto
Veronesi Umberto
Brindisi Joseph J.
Dow Kenneth J.
Goldberg Jerome D.
Ortho Pharmaceutical Corporation
LandOfFree
Methods of inhibiting development of leukoplakia with fenretinid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of inhibiting development of leukoplakia with fenretinid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of inhibiting development of leukoplakia with fenretinid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-197699